Christina Rossi
Geschäftsführer bei BLUEPRINT MEDICINES CORPORATION
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Christina Rossi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Geschäftsführer | 04.04.2022 | - |
| Corporate Officer/Principal | 29.10.2018 | 04.04.2022 | |
| XILIO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2021 | - |
| Independent Dir/Board Member | 01.04.2021 | - |
Karriereverlauf von Christina Rossi
Ehemalige bekannte Positionen von Christina Rossi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2012 | 01.10.2018 |
Eidetica Biopharma GmbH
 Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Eidetica Biopharma GmbH is a Swiss company that develops and manufactures biopharmaceutical drugs. The company is based in Zug, Switzerland. | Corporate Officer/Principal | 01.01.2005 | 01.01.2010 |
Ausbildung von Christina Rossi
| Duke University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 6 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Eidetica Biopharma GmbH
Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Eidetica Biopharma GmbH is a Swiss company that develops and manufactures biopharmaceutical drugs. The company is based in Zug, Switzerland. | Health Technology |
- Börse
- Insiders
- Christina Rossi
- Erfahrung
